• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Model Number AB2000
Device Problem Use of Device Problem (1670)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 07/29/2022
Event Type  Injury  
Event Description
A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation (procep) became aware that during treatment a prostatic capsule perforation occurred in the patient requiring a blood transfusion.Procept confirmed that the capsule perforation occurred due to the resection angle extending beyond the purple depth reference marker.Per the manufacturer's instructions for use, prostate capsule perforation and bleeding are perioperative risks of the aquablation procedure.Additionally, the ifu provides instructions to ensure the resection angle is not set beyond the prostate capsule and ensure the contour does not extend beyond the desired resection region.Failure to do so may result in prostatic capsule perforation.The patient was reported to be in good condition.
 
Manufacturer Narrative
Additional manufacturer narrative: root cause of reported event has not yet been established.Investigation by manufacturer is currently in-process.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Manufacturer Narrative
H.10 additional manufacturer narrative: the aquabeam robotic system was not returned for investigation of this event and is currently in use at the user facility.The investigation consisted of a review of the information reported to procept, plus a review of the event log files, device history record (dhr), and labeling.The aquabeam robotic system's treatment log file was reviewed, which confirmed no malfunctions during the aquablation procedure.The review of the treatment log file indicated that the system functioned as designed.A review of the device history record (dhr) ab2000-b rev.G / serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.Aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 4.3.Warnings: procedure as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: bleeding; bladder or prostate capsule perforation.5.6 precautions: procedure: when in the transverse trus view, ensure the resection angle is not set beyond the prostate capsule.When in the sagittal trus view, ensure the contour does not extend beyond the desired resection region.Failure to do so may result in prostatic capsule perforation.Ensure that the linear array of the trus probe is coplanar along the length of the aquabeam handpiece.Failure to do so may result in unintentional resection of prostatic tissue resulting in patient injury.Procept confirmed that the capsule perforation occurred due to the resection angle extending beyond the purple depth reference marker.Per the manufacturer's instructions for use, prostate capsule perforation and bleeding are perioperative risks of the aquablation procedure.Additionally, the ifu provides instructions to ensure the resection angle is not set beyond the prostate capsule and ensure the contour does not extend beyond the desired resection region.Failure to do so may result in prostatic capsule perforation.Based on the information received, plus the review of the event log files, dhr, and ifu, the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM ROBOTIC SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
Manufacturer (Section G)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
Manufacturer Contact
doria esquivel
900 island drive
suite 101
redwood city, CA 94065-1494
MDR Report Key15307402
MDR Text Key298766113
Report Number3012977056-2022-00110
Device Sequence Number1
Product Code PZP
UDI-Device IdentifierB614AB20001
UDI-Public+B614AB20001/16D20211001C
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAB2000
Device Catalogue NumberAB2000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/29/2022
Initial Date FDA Received08/26/2022
Supplement Dates Manufacturer Received11/14/2022
Supplement Dates FDA Received11/14/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/01/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-